Skip to content
Aminoscope
Goal

Injury recovery & tissue repair

“Healing” peptides are among the most-hyped in the space. The human evidence on BPC-157 is worth reading alongside recovery claims that draw on animal studies. The biology is genuinely interesting, but for most of these the controlled human evidence is thin and the compounds are unapproved and gray-market. Here is what each is actually supported to do.

By Julian RothResearch & data

The repair peptides

BPC-157, TB-500, and their newer stand-ins — the core of the recovery category.

PENTADECAPEPTIDE BPC 157 · TISSUE-REPAIR HYPOTHESISproposed repair — mostly rodent data

BPC 157: what the evidence actually shows (and what it doesn't)

The 'healing peptide' has a deep rodent literature and almost no human data. A straight read of where the science stands.

THYMOSIN β4 (TB-500) · ACTIN-SEQUESTERING PEPTIDEbound G-actin

TB-500 and thymosin beta-4: separating the trials from the hype

Real Phase 2 dry-eye data, deep preclinical neuro/cardiac work, and a recovery-market use that was never actually tested.

BPC-157TB-500THE “WOLVERINE STACK” · COMBINED RECOVERY PROTOCOLclaimed synergy — untestedtwo preclinical peptides, zero combination trials

Wolverine stack (BPC-157 + TB-500): what's in it and is it proven?

Popular, but proven? The combined BPC-157 + TB-500 recovery blend has a tidy mechanistic story and zero combination trials. A straight read of what the blend is, the theory, the FDA status, and the gaps.

BPC-157 vs TB-500: two recovery peptides on the same evidence ladderrecovery RCTother-use humananimal in vivocell / mechanismBPC-157TB-500 / thymosin β4Same rungs, neither reaches the topBOTH PRECLINICAL FOR RECOVERY · NO HUMAN RCT

BPC-157 vs TB-500: the recovery peptide pair, graded on evidence

They're sold as a matched 'healing stack,' but BPC-157 and TB-500 are unrelated molecules with different mechanisms and the same honest ceiling: overwhelmingly preclinical for recovery, with no human randomized trials.

assumption, not a findingPDA · no direct dataPENTADECA ARGINATE · A BORROWED EVIDENCE BASEBPC 157 — rodent studiesA REPOSITIONING AS MUCH AS A MOLECULE

Pentadeca Arginate (PDA): the evidence behind the BPC 157 successor

PDA is marketed as a more stable upgrade on BPC 157 — but it has almost no research of its own. A straight read of a borrowed evidence base.

Joints, tendons & skin

Targeted recovery — connective tissue, cartilage, and skin repair.

Gut & immune repair

The gut-lining and immune-modulating peptides used in recovery protocols.

LARAZOTIDE · AT-1001 · TIGHT-JUNCTION REGULATORgut lumen · gluten peptidesepithelial cellepithelial cellAT-1001tight junctiontightens the gut seal — celiac Phase 3 missed

Larazotide: the leaky-gut peptide that failed its Phase 3 trial

An 8-amino-acid tight-junction regulator with real celiac data and a failed pivotal trial — and why the supplement use runs far ahead of the evidence.

KPV, a melanocortin tripeptide, calming intestinal inflammation — preclinical evidence onlyKPVPRECLINICALKPV tripeptideinflamed gut (mouse models)KPV · THE C-TERMINAL TRIPEPTIDE OF α-MSH · WHAT THE EVIDENCE SHOWS

KPV peptide: what the evidence actually shows (benefits, dosage talk, and side effects)

KPV is the anti-inflammatory tripeptide tail of α-MSH, sold for gut, inflammation, wound-healing and skin. The mechanism is real and the mouse data are real — but there are essentially no human trials. A straight read of where the science stands.

Thymosin alpha-1: a thymic immune peptide, approved abroad for specific usesAPPROVEDABROADthymusimmune cellsTHYMOSIN α1 (Tα1) · A THYMIC IMMUNE PEPTIDEreal drug abroad — for specific immune uses, not general “wellness”

Thymosin alpha-1 peptide: benefits, evidence and how it's used

A real immune drug abroad, read against the wellness pitch. Tα1 (brand Zadaxin) is an approved immunomodulator in dozens of countries — for hepatitis, sepsis and severe infection, supervised. It is not FDA-approved, not the same as TB-500, and not the general anti-aging injectable sold online. The honest evidence, dosing and side-effect read.

EPOclassic EPO receptorred cells — no erythropoiesisinnate repair receptor (EPOR/CD131)tissue protection, healingARA-290 (cibinetide): an 11-aa peptide from EPOARA-290 · CIBINETIDE · INVESTIGATIONAL · PHASE 2

ARA-290 (cibinetide): the EPO-derived repair peptide and what its trials actually show

An 11-amino-acid peptide engineered from erythropoietin to protect tissue without making red cells. A straight read of the small-fiber-neuropathy evidence — and its limits.

Where to get it

Compare peptide therapy providers

Where to get the repair peptides through legitimate, physician-supervised channels — and why the source matters.

Compare providers →
Explore by goal